Bank Of Montreal Profound Medical Corp. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Profound Medical Corp. stock. As of the latest transaction made, Bank Of Montreal holds 11,670 shares of PROF stock, worth $92,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,670

Previous 11,535 1.17%

Holding current value

$92,426

Previous $98,000 1.02%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.25 - $9.07 $978 - $1,224	135 Added 1.17%	11,670 $97,000
Q1 2024 May 13, 2024	SELL	$7.3 - $9.46 $3,058 - $3,963	-419 Reduced 3.51%	11,535 $98,000
Q4 2023 Feb 08, 2024	SELL	$7.85 - $11.18 $730 - $1,039	-93 Reduced 0.77%	11,954 $101,000
Q3 2023 Nov 01, 2023	SELL	$7.91 - $13.27 $189 - $318	-24 Reduced 0.2%	12,047 $122,000
Q2 2023 Aug 02, 2023	SELL	$9.27 - $14.88 $210,614 - $338,073	-22,720 Reduced 65.3%	12,071 $157,000
Q1 2023 Jun 13, 2024	BUY	$8.85 - $13.27 $7,982 - $11,969	902 Added 7.82%	12,437 $115,000
Q4 2022 Feb 01, 2023	BUY	$3.18 - $10.91 $384 - $1,320	121 Added 0.35%	34,791 $378,000
Q3 2022 Nov 10, 2022	BUY	$3.99 - $9.3 $9,763 - $22,757	2,447 Added 7.59%	34,670 $174,000
Q2 2022 Aug 11, 2022	SELL	$6.34 - $9.53 $7,316 - $10,997	-1,154 Reduced 3.46%	32,223 $280,000
Q1 2022 May 12, 2022	BUY	$8.16 - $11.33 $2,064 - $2,866	253 Added 0.76%	33,377 $318,000
Q4 2021 Feb 11, 2022	BUY	$10.38 - $15.2 $42,516 - $62,259	4,096 Added 14.11%	33,124 $395,000
Q3 2021 Nov 12, 2021	SELL	$13.6 - $17.88 $532,358 - $699,894	-39,144 Reduced 57.42%	29,028 $451,000
Q2 2021 Aug 12, 2021	BUY	$16.0 - $20.59 $1.09 Million - $1.4 Million	68,172 New	68,172 $1.22 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

8.98M

Call Options Held

22.9K

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $165M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account